Answers are grounded in this paper and cite their sources.
Two patients developed asterixis while they were taking carbamazepine at "therapeutic" levels. The only laboratory abnormality was slight hyperammonemia. It occurred with normal hepatic function as a dose-related effect. In fact, the blood ammonia level decreased and asterixis ceased when carbamazepine was stopped or reduced in dosage. The relationship between asterixis and hyperammonemia during carbamazepine therapy is discussed.
No takes yet. Share an insight, caveat, or question.
Ambrosetto et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: